Your browser doesn't support javascript.
loading
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial.
Fong, Youyi; McDermott, Adrian B; Benkeser, David; Roels, Sanne; Stieh, Daniel J; Vandebosch, An; Le Gars, Mathieu; Van Roey, Griet A; Houchens, Christopher R; Martins, Karen; Jayashankar, Lakshmi; Castellino, Flora; Amoa-Awua, Obrimpong; Basappa, Manjula; Flach, Britta; Lin, Bob C; Moore, Christopher; Naisan, Mursal; Naqvi, Muhammed; Narpala, Sandeep; O'Connell, Sarah; Mueller, Allen; Serebryannyy, Leo; Castro, Mike; Wang, Jennifer; Petropoulos, Christos J; Luedtke, Alex; Hyrien, Ollivier; Lu, Yiwen; Yu, Chenchen; Borate, Bhavesh; van der Laan, Lars W P; Hejazi, Nima S; Kenny, Avi; Carone, Marco; Wolfe, Daniel N; Sadoff, Jerald; Gray, Glenda E; Grinsztejn, Beatriz; Goepfert, Paul A; Little, Susan J; Paiva de Sousa, Leonardo; Maboa, Rebone; Randhawa, April K; Andrasik, Michele P; Hendriks, Jenny; Truyers, Carla; Struyf, Frank; Schuitemaker, Hanneke; Douoguih, Macaya.
Afiliação
  • Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • McDermott AB; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Benkeser D; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Roels S; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
  • Stieh DJ; Janssen R&D, a division of Janssen Pharmaceutica NV, Beerse, Belgium.
  • Vandebosch A; Janssen Vaccines and Prevention, Leiden, the Netherlands.
  • Le Gars M; Janssen R&D, a division of Janssen Pharmaceutica NV, Beerse, Belgium.
  • Van Roey GA; Janssen Vaccines and Prevention, Leiden, the Netherlands.
  • Houchens CR; Janssen Vaccines and Prevention, Leiden, the Netherlands.
  • Martins K; Biomedical Advanced Research and Development Authority, Washington, DC, USA.
  • Jayashankar L; Biomedical Advanced Research and Development Authority, Washington, DC, USA.
  • Castellino F; Biomedical Advanced Research and Development Authority, Washington, DC, USA.
  • Amoa-Awua O; Biomedical Advanced Research and Development Authority, Washington, DC, USA.
  • Basappa M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Flach B; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Lin BC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Moore C; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Naisan M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Naqvi M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Narpala S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • O'Connell S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Mueller A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Serebryannyy L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Castro M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Wang J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Petropoulos CJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Luedtke A; LabCorp-Monogram Biosciences, South San Francisco, CA, USA.
  • Hyrien O; Department of Statistics, University of Washington, Seattle, WA, USA.
  • Lu Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Yu C; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Borate B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • van der Laan LWP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Hejazi NS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Kenny A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Carone M; Department of Statistics, University of Washington, Seattle, WA, USA.
  • Wolfe DN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Sadoff J; Division of Biostatistics, School of Public Health, Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
  • Gray GE; Department of Biostatistics, University of Washington School of Public Health, Seattle, WA, USA.
  • Grinsztejn B; Department of Biostatistics, University of Washington School of Public Health, Seattle, WA, USA.
  • Goepfert PA; Biomedical Advanced Research and Development Authority, Washington, DC, USA.
  • Little SJ; Janssen Vaccines and Prevention, Leiden, the Netherlands.
  • Paiva de Sousa L; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Maboa R; South African Medical Research Council, Cape Town, South Africa.
  • Randhawa AK; Evandro Chagas National Institute of Infectious Diseases-Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Andrasik MP; Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Hendriks J; Division of Infectious Diseases, University of California San Diego, La Jolla, CA, USA.
  • Truyers C; Evandro Chagas National Institute of Infectious Diseases-Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Struyf F; Ndlovu Elandsdoorn Site, Limpopo, Dennilton, South Africa.
  • Schuitemaker H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Douoguih M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Nat Microbiol ; 7(12): 1996-2010, 2022 12.
Article em En | MEDLINE | ID: mdl-36357712
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article